# Apryl

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/apryl

- Industry: Healthcare IT
- Headquarters: Berlin, Germany
- Website: https://apryl.co/
- Total disclosed funding: $4.5M
- Latest round: Seed (Mar 24, 2022)
- Investors on record: 7

## About

Based in Berlin, Germany, and founded in 2019, Apryl GmbH, formerly known as Oviavo, operates as a fertility benefits company. The company was founded by its CEO Jenny Saft and Tobias Kaufhold. In March 2022, Apryl GmbH raised EUR 4.1 million in a seed round led by Breega, Crista Galli Ventures, Myelin VC, and Westtech Ventures. The seed funding values Apryl GmbH at EUR 14.63 million post-money.

Apryl provides a fertility benefits platform that enables enterprises to support their employees. The firm offers a range of benefits, including consultations, family planning benefits, access to clinics and treatments, preliminary fertility assessments and testing, access to clinics for treatments like egg and sperm freezing, IVF, coverage for treatments and medication, and many more.

## Funding rounds

- Seed, Mar 24, 2022, $4.5M — Ventech Partners, Breega, Atlantic Labs, WestTech Ventures, Crista Galli Ventures, Myelin VC, Alliance For Impact Ventures

## Investors

- Ventech Partners (https://capitalatlas.ai/funds/ventech-partners) — Seed
- Breega (https://capitalatlas.ai/funds/breega) — Seed
- Atlantic Labs (https://capitalatlas.ai/funds/atlantic-labs) — Seed
- WestTech Ventures (https://capitalatlas.ai/funds/westtech-ventures) — Seed
- Crista Galli Ventures (https://capitalatlas.ai/funds/crista-galli-ventures) — Seed
- Myelin VC (https://capitalatlas.ai/funds/myelin-vc) — Seed
- Alliance For Impact Ventures (https://capitalatlas.ai/funds/alliance-for-impact-ventures) — Seed